knowledge -WSS

knowledge

author：leisure time 2025-09-30 23:11:12 - browse：86789

Dolly sheep — Alex Hogan/STAT, Getty Images

Dolly, the first animal to be cloned from an adult of its species, was born 20 years ago today at the Roslin Institute in Scotland. When her creators announced what they had done, it triggered warnings of rich people cloning themselves for spare parts, of tyrants cloning soldiers for armies, of bereaved parents cloning their dead child to produce a replacement — and promises that the technique would bring medical breakthroughs. Which raises some questions:

Why are there no human clones?

Because of scientific, ethical, and commercial reasons.

The scientists who created Dolly — named after Dolly Parton, naturally — removed the DNA from a sheep ovum, fused the ovum with a mammary epithelial cell from an adult “donor” sheep, and transplanted the result, now carrying DNA only from the donor, into a surrogate ewe. But that technique, called somatic cell nuclear transfer (SCNT), turned out not to be so easy in other species.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Readout LOUD podcast: A CRISPR milestone, biotech mixology

WSS

Ransomware attacks on hospitals: Study outlines patient impact

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

Morphosys mixed study results for blood cancer drug

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

NIH director takes cautious approach to Biden drug pricing priority

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

entertainment

knowledge

Why are there no human clones?

leisure time

Wildfire smoke exposes gaps in outdoor worker protections

Ransomware attacks on hospitals: Study outlines patient impact

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Ransomware attacks on hospitals: Study outlines patient impact

Duchenne breakthrough therapy leaves behind pioneering families

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

Jerome Adams on the need for new antivirals for Covid

Dewpoint Therapeutics lays off staff after losing partnerships

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

New brain studies show LSD's effects on the brain in full color

entertainment

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

How digital therapeutics firms are pivoting after Pear's bankruptcy

Think you might have Covid

Parkinson’s finding may lead to tests and, someday, treatments

Surge of respiratory disease in China has likely explanation

Think you might have Covid

leisure time

focus

entertainment

focus